Skip to main content
CHUGAI PHARMACEUTICAL CO., LTD. logo

CHUGAI PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 4519 ISIN · JP3519400000 LEI · 529900T9LAII161DCN95 T Manufacturing
Open in API
Filings indexed 81 across all filing types
Latest filing 2020-04-28 Interim / Quarterly Rep…
Country JP Japan
Listing T 4519

About CHUGAI PHARMACEUTICAL CO., LTD.

https://www.chugai-pharm.co.jp/english/

Chugai Pharmaceutical Co., Ltd. is a research and development-driven pharmaceutical company dedicated to creating innovative medical products to address unmet medical needs. As a member of the Roche Group, Chugai leverages its advanced expertise in biotechnology and science to develop novel treatments, establishing a leading position in therapeutic antibodies. The company's strategy emphasizes a shift towards discovery research and early clinical development, the integration of digital technologies, and open innovation through external partnerships. Its core therapeutic areas include oncology, rheumatology, and haemophilia, where it provides biopharmaceuticals and molecular targeted therapies to patients.

Recent filings

Filing Released Lang Actions
四半期報告書－第110期第1四半期(令和2年1月1日－令和2年3月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, as indicated by the header and the legal basis (Financial Instruments and Exchange Act). It contains comprehensive financial statements, management analysis (MDA), and operational updates for the first quarter of 2020 (January 1 to March 31). It is a formal, substantive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-04-28 Japanese
有価証券報告書－第109期(平成31年1月1日－令和1年12月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains the standard header information for such filings, including the fiscal year (2019), the company name (Chugai Pharmaceutical Co., Ltd.), and the regulatory submission details to the Kanto Local Finance Bureau. Given the comprehensive nature of this filing and its role as the primary annual financial disclosure, it is classified as a 10-K. FY 2019
2020-03-30 Japanese
四半期報告書－第109期第3四半期(2019/07/01－2019/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, as indicated by the header and the regulatory reference (Financial Instruments and Exchange Act). It contains comprehensive financial statements, management analysis, and audit review information for the third quarter of 2019. It is not an announcement or a short summary, but the full report itself, fitting the definition of an Interim/Quarterly Report (IR). 9M 2019
2019-10-30 Japanese
四半期報告書－第109期第2四半期(2019/04/01－2019/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a '四半期報告書' (Quarterly Report) filed with the Kanto Local Finance Bureau in Japan, pursuant to the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis (MDA), and operational data for the second quarter of 2019. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2019
2019-07-26 Japanese
四半期報告書－第109期第1四半期(2019/01/01－2019/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis (MD&A), and auditor review information for the first quarter of 2019. As it is a comprehensive financial report for a period shorter than a full fiscal year, it falls under the 'Interim / Quarterly Report' category. Q1 2019
2019-04-26 Japanese
有価証券報告書－第108期(平成30年1月1日－平成30年12月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the standard annual financial filing required by the Financial Services Agency of Japan under the Financial Instruments and Exchange Act. It contains comprehensive financial data, management indicators, and corporate history for the fiscal year ending December 31, 2018. This corresponds to the definition of an Annual Report (10-K). FY 2018
2019-03-28 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.